Market news

NewMediaWire Press Release.

In the latest trading session, Doximity (DOCS) closed at $26.52, marking a +1.22% move from the previous day.

SAN FRANCISCO, September 22, 2026--Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced that it has been named a founding partner in the launch of a new Specialized Intelligence Index of leading AI benchmarks compiled by Fireworks, the AI training and inference platform.

In the closing of the recent trading day, Doximity (DOCS) stood at $26.84, denoting a +2.8% move from the preceding trading day.

Detailed price information for Doximity Inc Cl A (DOCS-N) from The Globe and Mail including charting and trades.

Doximity (DOCS) closed at $25.81 in the latest trading session, marking a -2.2% move from the prior day.

A number of stocks jumped in the afternoon session after quarterly earnings and upbeat corporate commentary signaled that artificial intelligence is driving growth across enterprise software rather than threatening legacy business models.

Amplitude, GitLab, Doximity, Freshworks, and Sprinklr Shares Skyrocket, What You Need To Know

SAN FRANCISCO, August 25, 2026--Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced new data indicating that physicians are finding an unexpected source of optimism in AI. Rather than viewing the technology as a threat, nearly a quarter expect it to increase their total compensation within the next year, and two-thirds believe staying current with AI will give them a meaningful earnings edge over peers who don't.

DOCS' AI expansion is opening new growth avenues, but rising AI costs and tight pharma budgets could temper near-term gains.

Doximity stock has had a difficult five year stretch, with shareholders seeing the share price decline 71.8%, even as recent AI driven products have drawn fresh attention. At the current price near US$24.94, the key issue is whether the latest enthusiasm lines up with what the intrinsic value and market based checks say about Doximity. Over five years, the share price decline of 71.8% points to investors reassessing what they are willing to pay for Doximity. Growth expectations around...

Doximity (DOCS) is back in focus after its latest quarterly report showed higher sales, raised full year revenue guidance, and continued margin pressure tied to heavier spending on AI tools. See our latest analysis for Doximity. At a share price of US$24.94, Doximity has seen a 30 day share price return of 15.89% and a 90 day share price return of 25.58%. However, the year to date share price return is down 42.39% and the 1 year total shareholder return is down 60.79%. This points to...

This sale was executed under a pre-established Rule 10b5-1 trading plan adopted in February.

Sitaram's sale was driven by tax obligations from option exercises and RSU vesting, not a shift in conviction.

Restricted stock unit vesting triggered a routine sell-to-cover sale, reducing Zatz's direct holdings by 8% while leaving him with $1.3 million in remaining equity.

Tangney executed a non-discretionary sale to cover tax withholding on vesting equity awards.

Restricted stock unit vesting triggered a routine sell-to-cover sale, reducing Zatz's direct holdings by 8% while leaving him with $1.3 million in remaining equity.

Motley Fool Press Release.

A number of stocks jumped in the afternoon session after the Bureau of Labor Statistics reported that the July Producer Price Index was completely flat month-over-month—coming in below expectations for a 0.2% increase—following the Consumer Price Index print (released earlier in the week) which showed a mild 0.1% monthly increase and an annual inflation rate cooling to 3.4%. Together, the data points suggest price pressures are moderating across both wholesale and consumer levels, taking the urg

Doximity’s second quarter results were met with a notably positive market reaction following revenue that surpassed Wall Street expectations and ongoing momentum in its healthcare professional network. Management attributed the quarter’s growth to increased adoption of AI-powered clinical tools and rising engagement from both hospital and pharmaceutical clients. CEO Jeffrey Tangney highlighted, “Quarterly active workflow prescribers grew more than 30% year-on-year to record highs with nearly hal

For a few hours on August 7, Doximity, Inc. (NYSE:DOCS) appeared to be the story of the earnings season. The medical-networking platform’s stock more than doubled overnight following its fiscal first-quarter report, with CEO Jeffrey Tangney mentioning a metric that piqued traders’ interest: the company’s new AI Search product, he claimed on the results call, […]

Revenue estimates rise while near-term EBITDA falls

Detailed price information for 8X8 Inc (EGHT-Q) from The Globe and Mail including charting and trades.

Revenue grew 7% as AI adoption accelerated, with AI Scribe users surging 10-fold in July.

GitLab, UiPath, and Asana have similar setups that could lead to big post-earnings jumps.

Medical professional network Doximity (NYSE:DOCS) reported revenue ahead of Wall Street’s expectations in Q2 CY2026, with sales up 7.3% year on year to $156.6 million. The company expects next quarter’s revenue to be around $170.5 million, close to analysts’ estimates. Its non-GAAP profit of $0.29 per share was 4.2% below analysts’ consensus estimates.

These are some of the stocks posting the largest moves midday.

The leading digital platform for U.S. medical professionals is becoming a formidable force in the AI race.